Thalassemia Reports (Feb 2022)

Random Forest Clustering Identifies Three Subgroups of β-Thalassemia with Distinct Clinical Severity

  • Angela Vitrano,
  • Khaled M. Musallam,
  • Antonella Meloni,
  • Sebastiano Addario Pollina,
  • Mehran Karimi,
  • Amal El-Beshlawy,
  • Mahmoud Hajipour,
  • Vito Di Marco,
  • Saqib Hussain Ansari,
  • Aldo Filosa,
  • Paolo Ricchi,
  • Adriana Ceci,
  • Shahina Daar,
  • Efthymia Vlachaki,
  • Sylvia Titi Singer,
  • Zaki A. Naserullah,
  • Alessia Pepe,
  • Salvatore Scondotto,
  • Gabriella Dardanoni,
  • Fedele Bonifazi,
  • Vijay G. Sankaran,
  • Elliott Vichinsky,
  • Ali T. Taher,
  • Aurelio Maggio,
  • International Working Group on Thalassemia (IWG-THAL)

DOI
https://doi.org/10.3390/thalassrep12010004
Journal volume & issue
Vol. 12, no. 1
pp. 14 – 23

Abstract

Read online

In this work, we aimed to establish subgroups of clinical severity in a global cohort of β-thalassemia through unsupervised random forest (RF) clustering. We used a large global dataset of 7910 β-thalassemia patients and evaluated 19 indicators of phenotype severity (IPhS) to determine their contribution and relatedness in grouping β-thalassemia patients into clusters using RF analysis. RF clustering suggested that three clusters with minimal overlapping exist (classification error rate: 4.3%), and six important IPhS were identified: the current age of the patient, the mean serum ferritin level, the age at diagnosis, the age at first transfusion, the age at first iron chelation, and the number of complications. Cluster 3 represented patients with early initiation of transfusion and iron chelation, considerable iron overload, and early mortality from heart failure. Patients in Cluster 2 had lower serum ferritin levels, although they had a higher number of complications manifesting overtime. Patients in Cluster 1 represented a subgroup with delayed or absent transfusion and iron chelation, but with a high morbidity rate. Hepatic disease and cancer were dominant causes of death in patients in Cluster 1 and 2. Our findings established that patients with β-thalassemia can be clustered into three groups based on six parameters of phenotype severity.

Keywords